Technology News and Research

RSS

ZirMed forges alliance with Raintree Systems to jointly market their combined solutions

ZirMed®, a national provider of revenue cycle management services for healthcare practices, and leading integrated healthcare technology company Raintree Systems Inc. today announced a working partnership to jointly market their combined solutions to current and prospective customers. As a result of the partnership, ZirMed's flagship revenue cycle management platform will be integrated with Raintree's practice management and Electronic Medical Records (EMR) products, giving users state-of-the-art technology with which to better manage their daily operations.

2 Nov 2009

Artificial Medical Intelligence releases enhanced EMscribe CAC software

Artificial Medical Intelligence (AMI) today announced its newly enhanced EMscribe™ Computer Assisted Coding (CAC) software, version 4.0.

2 Nov 2009

PDI selects Veeva System’s CRM suite of multi-tenant SaaS applications

PDI, Inc., a leading provider of sales and marketing support to U.S. pharmaceutical companies, selected Veeva System’s VBioPharma CRM Primary Care and Special Care Editions, VMobile, and VInsights – all part of the Veeva CRM suite of multi-tenant SaaS applications. This marks PDI’s continued commitment to the technology advances in the world of cloud computing where business spending on SaaS/Cloud applications is expected to rise 22% this year to $9.6 billion, according to Gartner.

2 Nov 2009

Results of review by Marwood Group Advisory released by Amedisys

Amedisys, Inc., one of America's leading home health and hospice nursing companies, today released the results of a review conducted by Marwood Group Advisory, LLC (Marwood). Several months ago Amedisys engaged Marwood, one of the nation’s preeminent health care consulting firms, to provide an independent analysis of the Company’s procedures, controls, clinical infrastructure, corporate compliance processes, technology offerings and future strategies.

2 Nov 2009

Arrayit Corporation joins federal government in their efforts to help control health care costs

Arrayit Corporation is pleased to join the federal government in their efforts to help control health care costs by leveraging Arrayit's leading edge health care platform.

2 Nov 2009

Avila Therapeutics presents preclinical study data of its AVL-181 HCV protease inhibitor

Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.

2 Nov 2009

Alnylam Pharmaceuticals presents new data from its transthyretin-mediated amyloidosis program

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it presented new pre-clinical research findings from its transthyretin (TTR)-mediated amyloidosis (ATTR) program at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (“The Liver Meeting”).

2 Nov 2009

NIAID awards Pulmatrix $2.2M grant for developing novel influenza therapeutics

Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the treatment and prevention of infectious and progressive respiratory diseases, today announced that it has been awarded a grant for $2.2 million from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), aimed at advancing the development of novel influenza therapeutics for the treatment of seasonal and pandemic influenza.

2 Nov 2009

Pulmatrix raises $30.2 million through Series B financing

Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the treatment and prevention of infectious and progressive respiratory diseases, today announced that it has secured $30.2 million in Series B financing. ARCH Venture Partners and Novartis Bioventures Fund co-led the round with participation from existing investors Polaris Venture Partners and 5AM Ventures.

2 Nov 2009

Virtual world solution to address the unique needs of military amputees

Virtual worlds can provide military amputees with an opportunity to enhance their overall quality of life, expedite their reintegration into society, and improve their physical and mental wellness.

2 Nov 2009

New Aplio MX ultrasound system from Toshiba

Hospitals use ultrasound as a first-line diagnostic exam, requiring them to have cutting-edge ultrasound technology available to quickly and efficiently perform a range of patient exams. To meet these demanding clinical needs, while also considering the financial challenges facing many hospitals today, Toshiba America Medical Systems, Inc. has introduced the AplioTM MX ultrasound system, a compact system that offers premium clinical performance and high-end features at an affordable price point.

2 Nov 2009

Nuevolution receives milestone payment from Merck

Nuevolution A/S today announced that it has received a milestone payment derived from its collaboration with Merck & Co. Inc., Whitehouse Station, NJ.

2 Nov 2009

NOXXON Pharma commences human dosing in Spiegelmer NOX-A12 clinical trial

NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful initial dosing of healthy volunteers in a first-in-human clinical trial with Spiegelmer® NOX-A12. NOX-A12 is NOXXON’s second drug candidate entering the clinical stage of development within only five months.

2 Nov 2009

LRI and lupus organizations congratulate HGS and GlaxoSmithKline for achieving historical landmark

The Lupus Research Institute (LRI) and its National Coalition of state and local lupus organizations congratulate Human Genome Sciences (HGS) and GlaxoSmithKline for achieving an historical landmark - the second positive phase 3 clinical trial of Benlysta (belimumab), the first successfully tested new drug developed specifically for people with systemic lupus.

2 Nov 2009

Guided Therapeutics to launch LightTouch non-invasive cancer detection technology at Medica 2009

Guided Therapeutics, Inc. (GT) today announced plans to introduce its LightTouch™ non-invasive cancer detection technology at Medica 2009 in Düsseldorf, Germany November 18 - 20, 2009.

2 Nov 2009

Saft expands its portfolio with VL 10V Fe Super-Phosphate technology

Saft, the world specialist in the design and manufacture of high-tech batteries for industry, has expanded its range of lithium technologies with the VL 10V Fe Super-Phosphate(TM), the highest power lithium iron phosphate cell on the market. These large cells are designed for defense applications, such as U.S. Navy undersea operations, requiring very high power and safe operation.

2 Nov 2009

CNS cancer survivors have greater neurocognitive dysfunction than survivors of other types of cancer

Brain tumors in childhood cast a long shadow on survivors. The first study of the lasting impact of these tumors -- the most common solid malignancies in childhood -- shows that survivors have ongoing cognitive problems.

2 Nov 2009

China far outpaces research activities of rest of the world; expected to overtake USA in the next decade

A study from Thomson Reuters released today shows explosive growth in research output from China, far outpacing research activity in the rest of the world.

2 Nov 2009

WCMC-Q's biomedical research program makes significant progress

The biomedical research program of Weill Cornell Medical College in Qatar has made significant progress in its dual goals of advancing basic science and building a sustainable research community in Qatar since it was launched less than a year and a half ago.

2 Nov 2009

Dialysis patients with low body fat face high mortality rate

Dialysis patients with low body fat are at increased risk of death-even compared to patients at the highest level of body fat percentage, according to research being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego.

2 Nov 2009

Technology News and Research

ZirMed forges alliance with Raintree Systems to jointly market their combined solutions

Artificial Medical Intelligence releases enhanced EMscribe CAC software

PDI selects Veeva System’s CRM suite of multi-tenant SaaS applications

Results of review by Marwood Group Advisory released by Amedisys

Arrayit Corporation joins federal government in their efforts to help control health care costs

Avila Therapeutics presents preclinical study data of its AVL-181 HCV protease inhibitor

Alnylam Pharmaceuticals presents new data from its transthyretin-mediated amyloidosis program

NIAID awards Pulmatrix $2.2M grant for developing novel influenza therapeutics

Pulmatrix raises $30.2 million through Series B financing

Virtual world solution to address the unique needs of military amputees

New Aplio MX ultrasound system from Toshiba

Nuevolution receives milestone payment from Merck

NOXXON Pharma commences human dosing in Spiegelmer NOX-A12 clinical trial

LRI and lupus organizations congratulate HGS and GlaxoSmithKline for achieving historical landmark

Guided Therapeutics to launch LightTouch non-invasive cancer detection technology at Medica 2009

Saft expands its portfolio with VL 10V Fe Super-Phosphate technology

CNS cancer survivors have greater neurocognitive dysfunction than survivors of other types of cancer

China far outpaces research activities of rest of the world; expected to overtake USA in the next decade

WCMC-Q's biomedical research program makes significant progress

Dialysis patients with low body fat face high mortality rate

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News